InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Campbell Shannon. Director active across 2 companies, notably Black Diamond Therapeutics, Inc.. In total, 4 reports have been published. History available since 21 June 2024. The latest transaction was filed on 26 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Campbell Shannon is a declarant and a Director at Black Diamond Therapeutics, Inc. and Zentalis Pharmaceuticals, Inc. He has 4 filings in total, and the sampled recent filings run from 2024-06-21 to 2026-05-27, with buy and sell amounts of EUR 0 each. The modal transaction nature is Attribution.